← Open Payments lookup

BRIANNA AUSTIN: Open Payments

NPI 1316624455 · HARRISON, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$548 in 29 payments from 12 companies in 2025. Trend: 2023 $15 · 2024 $282 · 2025 $548

Food & beverage: $548
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.5$101
Alkermes, Inc.5$84
Otsuka America Pharmaceutical, Inc.3$62
Vanda Pharmaceuticals Inc.2$58
Supernus Pharmaceuticals, Inc.3$52
ABBVIE INC.3$49
Axsome Therapeutics, Inc.2$34
E.R. Squibb & Sons, L.L.C.1$32
Takeda Pharmaceuticals U.S.A., Inc.2$31
Collegium Pharmaceutical, Inc.1$16

Products named: INGREZZA, ARISTADA, REXULTI, VRAYLAR, Auvelity, COBENFY, TRINTELLIX, HETLIOZ.

Industry payments across AR — which companies pay providers there.